Cannabis and Schizophrenia: Genetics or Environment?
Episode Overview
Regular users of high-potency THC are at higher risk for developing psychosis. Genetic predisposition to schizophrenia does not fully explain cannabis-induced psychosis. Tailored clinical interventions are crucial for treating cannabis-related psychosis. Real-life examples highlight the severe consequences of cannabis-induced psychosis. Prevention strategies can significantly reduce the risk of developing psychotic disorders.
Regular users of high-potency THC have the highest odds of developing psychosis, independent of their genetic predisposition.
Ever wondered about the link between cannabis use and schizophrenia? This episode of High Truths on Drugs and Addiction dives into this complex topic with Dr. Marta DiForte, a leading psychiatrist and researcher from the UK. Dr. Roneet Lev, the host, brings her extensive experience in emergency and addiction medicine to the conversation, making it both informative and engaging.
The episode focuses on a significant study involving over 114,000 European patients to explore whether genetics or heavy cannabis use plays a bigger role in developing psychotic disorders. Dr. DiForte shares her findings that regular users of high-potency THC have the highest odds of developing psychosis, regardless of their genetic predisposition to schizophrenia. She also discusses her clinical practice in London, where she treats patients with cannabis-induced psychosis and highlights the importance of tailored interventions for these individuals.
The episode is filled with real-life examples, including a harrowing story of a young woman who experienced a one-time cannabis-induced psychosis with tragic results. Dr. DiForte's insights provide a deeper understanding of the risks associated with cannabis use and the potential for prevention and treatment. This episode is a must-listen for anyone interested in the intersection of cannabis use and mental health.